Orris

Gdm

Reading File
Finding Sources
Searching PubMed

"gestational diabetes mellitus" diagnosis management

Reading File
Reading File
Reading File
Reading File
Reading File
Here is a thorough overview of Gestational Diabetes Mellitus (GDM):

Gestational Diabetes Mellitus (GDM)

Definition

GDM is glucose intolerance first diagnosed during pregnancy that is not clearly pre-existing diabetes. Pathophysiology mirrors type 2 DM: advancing pregnancy causes significant insulin resistance (driven largely by placentally produced hormones, especially human placental lactogen), and a subset of women cannot maintain adequate compensatory insulin secretion. A small proportion (~6%) actually have pre-type 1 diabetes that manifests during pregnancy.
  • Prevalence: ~5-9% of pregnancies (two-step method) or ~8% overall

Risk Factors

  • Obesity
  • Age >25 years
  • Family history of T2DM or prior GDM
  • Ethnic groups: Hispanic, Native American, Asian, African American
  • Glucosuria on routine testing

Screening & Diagnosis

When to Screen

  • 24-28 weeks gestation (routine for all women)
  • Earlier in high-risk women (glucosuria, obesity, prior GDM, strong family history)
  • USPSTF: B recommendation for screening after 24 weeks; insufficient evidence before 24 weeks

Two-Step Approach (US standard - ADA/ACOG)

Step 1 - 50-g Glucose Challenge Test (GCT):
  • Given in fasting or non-fasting state
  • Plasma glucose at 1 hour
  • Positive threshold: ≥130-140 mg/dL (provider discretion; 130 mg/dL more sensitive, 140 mg/dL more specific)
Step 2 - 100-g, 3-hour OGTT (if Step 1 positive):
Time PointThreshold (Carpenter/Coustan)
Fasting≥95 mg/dL
1 hour≥180 mg/dL
2 hours≥155 mg/dL
3 hours≥140 mg/dL
  • 2 or more abnormal values = GDM diagnosis
  • ACOG 2018 notes women with even 1 abnormal value may be treated

One-Step Approach (IADPSG/WHO - international)

  • 75-g, 2-hour OGTT at 24-28 weeks
  • GDM diagnosed if any single value meets or exceeds:
Time PointThreshold
Fasting≥92 mg/dL (5.1 mmol/L)
1 hour≥180 mg/dL (10.0 mmol/L)
2 hours≥153 mg/dL (8.5 mmol/L)
  • Overt diabetes if fasting ≥126 mg/dL, 2-h ≥200 mg/dL, HbA1c ≥6.5%, or random glucose ≥200 mg/dL

Maternal & Fetal Complications

  • Macrosomia / large for gestational age (LGA)
  • Shoulder dystocia
  • Preeclampsia
  • Polyhydramnios
  • Fetal distress / fetal demise
  • Neonatal hypoglycemia (from fetal hyperinsulinemia)
  • Increased cesarean delivery rate
  • Long-term: GDM confers a 7-10-fold increased risk of T2DM; ~10% risk within 5 years of delivery

Management

Glycemic Targets in Pregnancy

TimingTarget
Fasting<95 mg/dL (<5.3 mmol/L)
1-hour postprandial<140 mg/dL (<7.8 mmol/L)
2-hour postprandial<120 mg/dL (<6.7 mmol/L)

First-line: Medical Nutrition Therapy (MNT)

  • Effective in the majority of GDM women
  • Aim to optimize normoglycemia and appropriate gestational weight gain

Pharmacotherapy (when MNT insufficient):

  • Insulin - preferred therapy (safest profile, lowest treatment failure rate)
    • Insulin needs increase across trimesters: 0.7-0.8 u/kg (T1) → 0.8-1.0 u/kg (T2) → 0.9-1.2 u/kg (T3)
    • Typically basal + prandial regimen
  • Metformin - alternative if patient declines/cannot take insulin; lower mean birth weights, gestational weight gain, and preeclampsia vs. insulin; however, unknown long-term effects on child metabolic programming (higher childhood adiposity) inform preference for insulin
  • Glyburide - another oral alternative; now less preferred due to higher neonatal hypoglycemia risk vs. metformin

Monitoring

  • Fasting and 1- or 2-hour postprandial glucose daily minimum
  • HbA1c has limited utility in pregnancy (falsely low due to increased RBC turnover)
  • Continuous glucose monitoring (CGM) is evidence-based for T1DM in pregnancy; role in GDM evolving
  • Serial ultrasounds for LGA / polyhydramnios

Delivery

  • Induction considered at 37-39 weeks
  • Cesarean reserved for estimated fetal weight ≥4500 g (to minimize shoulder dystocia risk)
  • Tight glycemic control at delivery to prevent neonatal hypoglycemia

Postpartum Follow-up

  • 2-hour 75-g OGTT at 4-12 weeks postpartum to screen for persistent diabetes or impaired glucose tolerance
  • All women should be counseled on long-term T2DM and cardiovascular risk
  • Exercise, weight loss, and metformin reduce subsequent T2DM risk in these women
Sources: Creasy & Resnik's Maternal-Fetal Medicine, p. 1427 | Harrison's Principles of Internal Medicine 22E | Textbook of Family Medicine 9e
This is a shared conversation. Sign in to Orris to start your own chat.